Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-10

Clinical Trial Update: Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing efavirenz or atazanavir/ritonavir with emtricitabine/tenofovir disoproxil fumarate or abacavir/lamivudine in treatment-naive HIV patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atazanavir/ritonavir (atazanavir/ritonavir)
  • EFAVIRENZ (efavirenz)
  • Emtricitabine/Tenofovir disoproxil fumarate (emtricitabine/tenofovir disoproxil fumarate)
  • abacavir/lamivudine (abacavir/lamivudine)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2011-01-10